Cargando…
P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072310/ http://dx.doi.org/10.1186/2051-1426-2-S2-P2 |
| _version_ | 1782322939123728384 |
|---|---|
| author | Neuberger, M Paustian, C Hilton, T Engel, N Reu, S Linder, A Huber, R Hatz, R Winter, H |
| author_facet | Neuberger, M Paustian, C Hilton, T Engel, N Reu, S Linder, A Huber, R Hatz, R Winter, H |
| author_sort | Neuberger, M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4072310 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40723102014-06-27 P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials Neuberger, M Paustian, C Hilton, T Engel, N Reu, S Linder, A Huber, R Hatz, R Winter, H J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072310/ http://dx.doi.org/10.1186/2051-1426-2-S2-P2 Text en Copyright © 2014 Neuberger et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Neuberger, M Paustian, C Hilton, T Engel, N Reu, S Linder, A Huber, R Hatz, R Winter, H P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials |
| title | P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials |
| title_full | P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials |
| title_fullStr | P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials |
| title_full_unstemmed | P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials |
| title_short | P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials |
| title_sort | p11. developing an immunotherapy strategy for the effective treatment of patients with non small cell lung cancer (nsclc): strategies to evaluate immunity in patients on clinical trials |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072310/ http://dx.doi.org/10.1186/2051-1426-2-S2-P2 |
| work_keys_str_mv | AT neubergerm p11developinganimmunotherapystrategyfortheeffectivetreatmentofpatientswithnonsmallcelllungcancernsclcstrategiestoevaluateimmunityinpatientsonclinicaltrials AT paustianc p11developinganimmunotherapystrategyfortheeffectivetreatmentofpatientswithnonsmallcelllungcancernsclcstrategiestoevaluateimmunityinpatientsonclinicaltrials AT hiltont p11developinganimmunotherapystrategyfortheeffectivetreatmentofpatientswithnonsmallcelllungcancernsclcstrategiestoevaluateimmunityinpatientsonclinicaltrials AT engeln p11developinganimmunotherapystrategyfortheeffectivetreatmentofpatientswithnonsmallcelllungcancernsclcstrategiestoevaluateimmunityinpatientsonclinicaltrials AT reus p11developinganimmunotherapystrategyfortheeffectivetreatmentofpatientswithnonsmallcelllungcancernsclcstrategiestoevaluateimmunityinpatientsonclinicaltrials AT lindera p11developinganimmunotherapystrategyfortheeffectivetreatmentofpatientswithnonsmallcelllungcancernsclcstrategiestoevaluateimmunityinpatientsonclinicaltrials AT huberr p11developinganimmunotherapystrategyfortheeffectivetreatmentofpatientswithnonsmallcelllungcancernsclcstrategiestoevaluateimmunityinpatientsonclinicaltrials AT hatzr p11developinganimmunotherapystrategyfortheeffectivetreatmentofpatientswithnonsmallcelllungcancernsclcstrategiestoevaluateimmunityinpatientsonclinicaltrials AT winterh p11developinganimmunotherapystrategyfortheeffectivetreatmentofpatientswithnonsmallcelllungcancernsclcstrategiestoevaluateimmunityinpatientsonclinicaltrials |